Clinical data | |
---|---|
Other names | Ethylnorandrostenol; 17α-Ethyl-19-norandrost-5-en-17β-ol |
Routes of administration | By mouth |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.037.226 |
Chemical and physical data | |
Formula | C20H32O |
Molar mass | 288.475 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Bolenol (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name), also known as 17α-ethyl-19-norandrost-5-en-17β-ol (ethylnorandrostenol), is a synthetic, orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivativeof19-nortestosterone (nandrolone) that was never marketed.[1] It was described in the literature in 1969.[1]
This article about a steroid is a stub. You can help Wikipedia by expanding it. |
This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |